PMID:21185072: Difference between revisions
| Line 195: | Line 195: | ||
[[Category:Actinomycin D]] | [[Category:Actinomycin D]] | ||
[[Category:Amikacin]] | [[Category:Amikacin]] | ||
[[Category:Ammonium Chloride]] | |||
[[Category:Amoxicillin]] | [[Category:Amoxicillin]] | ||
[[Category:Ampicillin]] | [[Category:Ampicillin]] | ||
| Line 205: | Line 206: | ||
[[Category:Bile]] | [[Category:Bile]] | ||
[[Category:Bleomycin]] | [[Category:Bleomycin]] | ||
[[Category: | [[Category:Calcofluor]] | ||
[[Category:Carbenicillin]] | [[Category:Carbenicillin]] | ||
[[Category:Carbonyl Cyanide 3-Chlorophenylhydrazone (CCCP)]] | |||
[[Category:Cecropin B]] | [[Category:Cecropin B]] | ||
[[Category:Cefaclor]] | [[Category:Cefaclor]] | ||
[[Category:Cefoxitin]] | [[Category:Cefoxitin]] | ||
[[Category: | [[Category:Cefsulodin]] | ||
[[Category:Ceftazidime]] | |||
[[Category:Cerulenin]] | |||
[[Category:CHIR 090]] | |||
[[Category:Chloramphenicol]] | |||
[[Category:Chloropromazine]] | |||
[[Category:Cholate]]Ciprofloxacin]] | |||
[[Category:Cisplatin]] | |||
[[Category:Clarythromycin]] | |||
[[Category:Cycloserine D]] | |||
[[Category:Deoxycholate]] | |||
[[Category:Dibucaine]] | |||
[[Category:Doxorubin]] | |||
[[Category: | |||
[[Category: | |||
[[Category:Epinephrine]] | |||
[[Category:Erythromycin]] | |||
[[Category:Ethanol]] | |||
[[Category:Ethidium Bromide]] | |||
[[Category:Fosfomycin]] | |||
[[Category:Fusidicacid]] | |||
[[Category:Gentamycin]] | |||
[[Category:Glucosamine]] | |||
[[Category:Glucose]] | |||
[[Category:Glufosfomycin]] | |||
[[Category:Glycerol]] | |||
[[Category:High Cobalt (Co)]] | |||
[[Category:High Copper (Cu)]] | |||
[[Category:High Iron (Fe)]] | |||
[[Category:High Nickel (Ni)]] | |||
[[Category:Hydroxyurea (HU)]] | |||
[[Category:Indolicidin]] | |||
[[Category:Isoniazid]] | |||
[[Category:Levofloxacin]] | |||
[[Category:Low Iron (Fe)]] | |||
[[Category:Maltose]] | |||
[[Category:Mecillinam]] | |||
[[Category:Methotrexate]] | |||
[[Category:Minocycline]] | |||
[[Category:Mitomycin C]] | |||
[[Category:MMS]] | |||
[[Category:Nalidixic Acid]] | |||
[[Category:High Sodium Chloride (NaCl)]] | |||
[[Category:Nigericin]] | |||
[[Category:Nitrofurantoin]] | |||
[[Category:Norepinephrine]] | |||
[[Category:Norfloxacin]] | |||
[[Category:Novobiocin]] | |||
[[Category:Oxacilliin]] | |||
[[Category:Paraquat]] | |||
[[Category:Peroxide]] | |||
[[Category:pH]] | |||
[[Category:Phleomycin]] | |||
[[Category:PMS]] | |||
[[Category:Polymyxin B]] | |||
[[Category:Procaine]] | |||
[[Category:Propidium Iodide]] | |||
[[Category:Puromycin]] | |||
[[Category:Pyocyanin]] | |||
[[Category:Radicicol]] | |||
[[Category:Rifampicin]] | |||
[[Category:Spectinomycin]] | |||
[[Category:Spiramycin]] | |||
[[Category:Streptomycin]] | |||
[[Category:Streptonigrin]] | |||
[[Category:Succinate]] | |||
[[Category:Sulfamethizole]] | |||
[[Category:Sulfamonomethoxine]] | |||
[[Category:Taurocholate]] | |||
[[Category:Tetracycline]] | |||
[[Category:Theophylline]] | |||
[[Category:Thiolactomycin]] | |||
[[Category:Tobramycin]] | |||
[[Category:Triclosan]] | |||
[[Category:Trimethoprim]] | |||
[[Category:Trimethoprim-Sulfamethizole]] | |||
[[Category:Triton X]] | |||
[[Category:Tunicamycin]] | |||
[[Category:Ultraviolet Radiation (UV)]] | |||
[[Category:Vancomycin]] | |||
[[Category:Verapamil]] | |||
Revision as of 19:38, 13 April 2011
| Citation |
Nichols, RJ, Sen, S, Choo, YJ, Beltrao, P, Zietek, M, Chaba, R, Lee, S, Kazmierczak, KM, Lee, KJ, Wong, A, Shales, M, Lovett, S, Winkler, ME, Krogan, NJ, Typas, A and Gross, CA (2011) Phenotypic landscape of a bacterial cell.Cell 144:143-56 |
|---|---|
| Abstract |
The explosion of sequence information in bacteria makes developing high-throughput, cost-effective approaches to matching genes with phenotypes imperative. Using E. coli as proof of principle, we show that combining large-scale chemical genomics with quantitative fitness measurements provides a high-quality data set rich in discovery. Probing growth profiles of a mutant library in hundreds of conditions in parallel yielded > 10,000 phenotypes that allowed us to study gene essentiality, discover leads for gene function and drug action, and understand higher-order organization of the bacterial chromosome. We highlight new information derived from the study, including insights into a gene involved in multiple antibiotic resistance and the synergy between a broadly used combinatory antibiotic therapy, trimethoprim and sulfonamides. This data set, publicly available at http://ecoliwiki.net/tools/chemgen/, is a valuable resource for both the microbiological and bioinformatic communities, as it provides high-confidence associations between hundreds of annotated and uncharacterized genes as well as inferences about the mode of action of several poorly understood drugs. |
| Links | |
| Keywords |
phenotype; phenomic profiling; phenotypic signature; hierarchical clustering; responsive genome; high-throughput; chemical genomics; stress; essential; function; antibiotic resistance; synergy |
| edit table |
Main Points of the Paper
- Key Motivation- provide phenotypes for mutants of genes without functional annotation
- Central Goal- systematically evaluate the impact of every gene deletion on E.coli fitness in diverse environments
- Phenomic Profiling- quantitative description of the response of all single-gene deletions to physiologically relevant stresses and drug challenges
- profiled ~4,000 genes in 324 conditions covering 114 unique stresses (more than half were antimicrobial/antibiotic stress)
- identified thousands of phenotypes
- identified a diverse set of conditionally essential genes
- Identified 116 rich-media conditionally essential (CE) genes
- facilitates high-confidence association of genes of unknown function to those of known function
- generates numerous leads concerning drug function
- Hierarchical clustering
- Phenotypic Signature- response of each mutant strain across all conditions
- high correlation b/t two phenotypic signatures implies a functional connection b/t genes
Materials and Methods Used
Strain Details
- Keio single-gene deletion library
- essential gene hypomorphs
- RNA/small protein knockout library
Equipment and Reagents
Procedure
Data Analysis
Hierarchical clustering
Phenotype Annotations
See Help:AnnotationTable for details on how to edit this table.
| Species | Taxon ID | Strain | Gene (if known) | OMP | Phenotype | Details | Evidence | Notes |
|---|---|---|---|---|---|---|---|---|
|
Escherichia coli |
K-12 BW25113 |
ECK3620-RFAP |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
rfaP phosphorylates core heptose of lipopolysaccharide | |
|
Escherichia coli |
K-12 BW25113 |
ECK0223-LPCA |
sensitivity to 1.2 mM DIBUCAINE |
Growth |
slow growth |
Growth Curve |
the target of DIBUCAINE is the membrane (pmf) | |
|
Escherichia coli |
K-12 BW25113 |
ECK3610-RFAF |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
rfaF = ADP-heptose:LPS heptosyltransferase II target of bile salts: membrane | |
|
Escherichia coli |
K-12 BW25113 |
ECK3042-RFAE |
sensitivity to 30 µg/ml NOVOBIOCIN |
Growth |
slow growth |
Growth Curve |
ECK3042-RFAE = heptose 7-phosphate kinase/heptose 1-phosphate adenyltransferase the target of NOVOBIOCIN is DNA gyrase | |
|
Escherichia coli |
K-12 BW25113 |
ECK3610-RFAE |
sensitivity to 0.1% bile salts |
Growth |
slow growth |
Growth Curve |
ECK3042-RFAE = heptose 7-phosphate kinase/heptose 1-phosphate adenyltransferase target of bile salts: membrane
| |
| edit table |
Notes
References
See Help:References for how to manage references in OMPwiki. Ciprofloxacin]] [[Category: [[Category:
a
c
h
p
t